Literature DB >> 31515266

Global tuberculosis prevention: should we start from the beginning?

Giovanni Sotgiu1, Delia Goletti2, Alberto Matteelli3.   

Abstract

Entities:  

Mesh：

Year:  2019        PMID： 31515266     DOI： 10.1183/13993003.01394-2019

Source DB:  PubMed          Journal:  Eur Respir J        ISSN： 0903-1936            Impact factor:   16.671


× No keyword cloud information.
  6 in total

1.  QuantiFERON-TB Gold Plus with Chemiluminescence Immunoassay: Do We Need a Higher Cutoff?

Authors:  Francesco Bisognin; Giulia Lombardi; Maria Carla Re; Paola Dal Monte
Journal:  J Clin Microbiol       Date:  2020-09-22       Impact factor: 5.948

2.  Country-specific approaches to latent tuberculosis screening targeting migrants in EU/EEA* countries: A survey of national experts, September 2019 to February 2020.

Authors:  Ioana Margineanu; Kieran Rustage; Teymur Noori; Dominik Zenner; Christina Greenaway; Manish Pareek; Onno Akkerman; Sally Hayward; Jon S Friedland; Delia Goletti; Ymkje Stienstra; Sally Hargreaves
Journal:  Euro Surveill       Date:  2022-03

3.  Significance of LncRNA CASC8 genetic polymorphisms on the tuberculosis susceptibility in Chinese population.

Authors:  Guoye Liu; Rui Xia; Qian Wang; Zhiqiang Wang; Binwu Ying; Hong Yan
Journal:  J Clin Lab Anal       Date:  2020-02-07       Impact factor: 2.352

4.  Epidemic Trends in High Tuberculosis Burden Countries During the Last Three Decades and Feasibility of Achieving the Global Targets at the Country Level.

Authors:  Cheng Ding; Ming Hu; Yanwan Shangguan; Wanru Guo; Shuting Wang; Xuewen Feng; Zunjing Zhang; Ying Zhang; Kaijin Xu
Journal:  Front Med (Lausanne)       Date:  2022-03-03

5.  Serum Biomarker Profile Including CCL1, CXCL10, VEGF, and Adenosine Deaminase Activity Distinguishes Active From Remotely Acquired Latent Tuberculosis.

Authors:  Eveline M Delemarre; Laura van Hoorn; Aik W J Bossink; Julia Drylewicz; Simone A Joosten; Tom H M Ottenhoff; Onno W Akkerman; Delia Goletti; Elisa Petruccioli; Assunta Navarra; Brigitte T A van den Broek; Sanne P A Paardekooper; Ineke van Haeften; Leo Koenderman; Jan-Willem J Lammers; Steven F T Thijsen; Regina W Hofland; Stefan Nierkens
Journal:  Front Immunol       Date:  2021-10-07       Impact factor: 7.561

6.  Effect of HIV-infection on QuantiFERON-plus accuracy in patients with active tuberculosis and latent infection.

Authors:  Elisa Petruccioli; Teresa Chiacchio; Assunta Navarra; Valentina Vanini; Gilda Cuzzi; Claudia Cimaglia; Luigi Ruffo Codecasa; Carmela Pinnetti; Niccolò Riccardi; Fabrizio Palmieri; Andrea Antinori; Delia Goletti
Journal:  J Infect       Date:  2020-02-22       Impact factor: 6.072
  6 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.